Piet Wigerinck
Net worth: 124 266 $ as of 2026-05-30
Net worth: 124 266 $ as of 2026-05-30
Currently, Piet Wigerinck is Chief Scientific Officer of Galapagos NV. He is also on the board of Ipsen SA and Ipsen Pharma SAS. In the past he was Vice President-Drug Discovery & Early Development at Tibotec Pharmaceuticals and Vice President of Drug Discovery & Development Solutions Ltd. Dr. Wigerinck received a doctorate from Katholieke Universiteit Leuven.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IPSEN SA 0% | 2025-12-30 | 680 ( 0% ) | 124 266 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| IPSEN | Director/Board Member | 2018-04-30 |
Antwerp University Hospital
Antwerp University Hospital Hospital/Nursing ManagementHealth Services Provides clinical, patient care, academic training and scientific research services | Director/Board Member | - |
miDIAGNOSTICS NV
miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services Develops a computer chip powered portable medical laboratory | Director/Board Member | - |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Director/Board Member | - |
Symeres BV
Symeres BV BiotechnologyHealth Technology Operates as a contract research organization for drug discovery and development activities | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Chief Tech/Sci/R&D Officer | 2021-12-30 |
UZA Foundation | Director/Board Member | - |
Xinvento BV
Xinvento BV BiotechnologyHealth Technology Operates as a biotech company that develops therapies for congenital hyperinsulinism | Founder | - |
Tibotec Virco Comm. VA
Tibotec Virco Comm. VA Pharmaceuticals: MajorHealth Technology Provides medicine | Corporate Officer/Principal | - |
| ░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Antwerp University Hospital
Antwerp University Hospital Hospital/Nursing ManagementHealth Services Provides clinical, patient care, academic training and scientific research services | Health Services |
Tibotec Virco Comm. VA
Tibotec Virco Comm. VA Pharmaceuticals: MajorHealth Technology Provides medicine | Health Technology |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
miDIAGNOSTICS NV
miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services Develops a computer chip powered portable medical laboratory | Commercial Services |
Drug Discovery & Development Solutions Ltd.
Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in drug discovery and development | Commercial Services |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
Symeres BV
Symeres BV BiotechnologyHealth Technology Operates as a contract research organization for drug discovery and development activities | Health Technology |
Xinvento BV
Xinvento BV BiotechnologyHealth Technology Operates as a biotech company that develops therapies for congenital hyperinsulinism | Health Technology |
UZA Foundation |
Select your edition
All financial news and data tailored to specific country editions